Eton Pharmaceuticals, Inc. (ETON) Financials
ETON Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 31.7 million | 16.3 million |
2023-09-30 | 31.5 million | 14.6 million |
2023-06-30 | 30.9 million | 14.2 million |
2023-03-31 | 23.9 million | 12.7 million |
ETON Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -388000 | 750000 |
2023-09-30 | 873000 | 730000 |
2023-06-30 | 7.1 million | 785000 |
2023-03-31 | -1.5 million | 872000 |
ETON Net Income
No data available :(
ETON Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 22000 |
2023-09-30 | 22.1 million | - | 44000 |
2023-06-30 | 21.6 million | - | 66000 |
2023-03-31 | 14.7 million | 5.1 million | 86000 |
ETON Shares Outstanding
ETON Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.0 million | 4.6 million | - |
2023-09-30 | - | 615000 | 4.3 million | - |
2023-06-30 | - | 1.1 million | 4.7 million | - |
2023-03-31 | - | 535000 | 5.3 million | - |
ETON Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 7.3 million | 3.7 million |
2023-09-30 | 7.0 million | 2.6 million |
2023-06-30 | 12.0 million | 2.3 million |
2023-03-31 | 5.3 million | 2.0 million |
ETON
Price: $3.45
52 week price:
Earnings Per Share: -0.04 USD
P/E Ratio: -449
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 36257
Market Capitalization: 92.2 million